A Phase I/II safety, pharmacokinetic and pharmacodynamic

Project: Research project

Project Details

Description

A Phase I/II safety, pharmacokinetic, and pharmacodynamic study of APS001F with flucytosine and maltose for the treatment of advanced and/or metastatic solid tumors.
StatusActive
Effective start/end date2/3/152/28/21

Funding

  • ANAEROPHARMA SCIENCE, INC.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.